2023年8月17日,UBS调整了对GE HealthCare Technologies Inc. (NASDAQ:GEHC)的立场,将该股评级从中性下调至卖出。该公司还将目标价从之前的84美元下调至74美元。 UBS分析师表示,当前股价已充分反映了预期收益,但未考虑潜在风险,尤其是来自中国市场的风险,这促使他们做出了这一举动。 GE HealthCare的股价今年大幅上涨,涨幅约为20%,接近历 ...
GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...
GE HealthCare Technologies Inc. is a leading provider in the healthcare sector, specializing in the development, manufacture, and marketing of a wide range of products and digital solutions.